Abstract
This paper aims to summarize conference proceedings and testimonies from the “Empowering Women to Take Control of Their Sexual Health Summit” convened in South Florida. In the present study, the phrase “women of color” refers to 279 cisgender and transgender African American, Latina, and Haitian women. Data were collected through three 90-minute group discussions conducted at the conference Individual-, social-, and structural-level PrEP barriers and facilitators were identified. Individual level barriers included: medical distrust, limited knowledge about PrEP, and economic dependence on sexual partners. Participants discussed cultural gender norms and roles as overarching social barriers, with religiosity reinforcing these norms. Structural barriers included: health literacy, health insurance coverage, immigration status, and structural racism. Community attributes that acted as facilitators of PrEP use were resilience and adaptability. Increasing PrEP utilization among women of color requires a multi-tiered approach to comprehensively address structural and community level barriers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the following grant awards: #U34AA026219 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); #K99/R00 DA046311 from the National Institute on Drug Abuse (NIDA); and Gilead Award #03411. These sponsors were not involved in the study design, collection, analysis, and interpretation B) Title Page (showing Author Details) of data. The views expressed here belong solely to the authors and do not necessarily reflect those of the sponsoring institutions.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The summit participants were not considered research participants, but community stakeholders and no identifiable information or personal data was collected. The study was initially approved by The Social and Behavioral Institutional Review Board of Florida International University on 11/2/17 and is still active. FIU IRB protocol approval number is: IRB-17-0353-CR04
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
